Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review
出版年份 2015 全文链接
标题
Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 10, Issue 12, Pages 3579-3593
出版商
Informa UK Limited
发表日期
2015-02-11
DOI
10.4161/21645515.2014.980197
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults
- (2014) Nozomi Takeshita et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012
- (2014) Yu Liu et al. VACCINE
- Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan
- (2014) Li-Min Huang et al. VACCINE
- WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012
- (2013) Dennis W. Trent et al. BIOLOGICALS
- Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain
- (2013) Chiaki Miyazaki et al. Clinical and Vaccine Immunology
- Is a Booster Dose Necessary in Children after Immunization with Live Attenuated Japanese Encephalitis Vaccine?
- (2013) U. Y. Choi et al. JOURNAL OF TROPICAL PEDIATRICS
- Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children
- (2013) Emmanuel Feroldi et al. Human Vaccines & Immunotherapeutics
- A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines
- (2012) E. O. Erra et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
- (2012) Tabitha Woolpert et al. VACCINE
- Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children
- (2012) Kenji Okada et al. VACCINE
- Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)
- (2012) Akiko Kikukawa et al. VACCINE
- Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial
- (2012) Emmanuel Feroldi et al. Human Vaccines & Immunotherapeutics
- Effectiveness of the Viet Nam Produced, Mouse Brain-Derived, Inactivated Japanese Encephalitis Vaccine in Northern Viet Nam
- (2012) Florian Marks et al. PLoS Neglected Tropical Diseases
- Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
- (2011) Na Jia et al. BMC INFECTIOUS DISEASES
- Estimated global incidence of Japanese encephalitis:
- (2011) Grant Campbell et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- New Japanese encephalitis vaccines: alternatives to production in mouse brain
- (2011) Scott B Halstead et al. Expert Review of Vaccines
- Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine
- (2011) Peter E Nasveld et al. Human vaccines & immunotherapeutics
- Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine
- (2011) Peter E. Nasveld et al. Human vaccines & immunotherapeutics
- Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51
- (2011) Susanne Eder et al. VACCINE
- Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®
- (2011) Elisabeth Schuller et al. VACCINE
- Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study
- (2011) Charung Muangchana et al. VACCINE
- IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine
- (2010) Mohan Babu Appaiahgari et al. Expert Review of Vaccines
- Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds
- (2010) Kulkanya Chokephaibulkit et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine
- (2010) Thanyawee Puthanakit et al. VACCINE
- Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
- (2010) Katrin Dubischar-Kastner et al. VACCINE
- Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
- (2010) Joseph Torresi et al. VACCINE
- Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis
- (2009) Rashmi Kumar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
- (2009) Elisabeth Schuller et al. VACCINE
- Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
- (2009) A. Kaltenböck et al. VACCINE
- Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
- (2009) A. Kaltenböck et al. VACCINE
- A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
- (2008) Young Mo Sohn et al. VACCINE
- Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51
- (2008) E. Schuller et al. VACCINE
- Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
- (2008) Salvacion Gatchalian et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started